Cargando…

Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo

CONTEXT: Curcumin (Cur) has a short duration of action which limits its therapeutic efficacy. Carbonic acid 17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 4-[7-(4-hydroxy-3-methoxy-phenyl)-3,5-dioxo-hepta-1,6-dienyl]-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wenmei, Zeng, Mingtang, Li, Ke, Pi, Chao, Liu, Zerong, Zhan, Chenglin, Yuan, Jiyuan, Su, Zhilian, Wei, Yuxun, Wen, Jie, Pi, Fengjuan, Song, Xinjie, Lee, Robert J., Wei, Yumeng, Zhao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704087/
https://www.ncbi.nlm.nih.gov/pubmed/36606719
http://dx.doi.org/10.1080/13880209.2022.2136205
_version_ 1784839986010390528
author Zhao, Wenmei
Zeng, Mingtang
Li, Ke
Pi, Chao
Liu, Zerong
Zhan, Chenglin
Yuan, Jiyuan
Su, Zhilian
Wei, Yuxun
Wen, Jie
Pi, Fengjuan
Song, Xinjie
Lee, Robert J.
Wei, Yumeng
Zhao, Ling
author_facet Zhao, Wenmei
Zeng, Mingtang
Li, Ke
Pi, Chao
Liu, Zerong
Zhan, Chenglin
Yuan, Jiyuan
Su, Zhilian
Wei, Yuxun
Wen, Jie
Pi, Fengjuan
Song, Xinjie
Lee, Robert J.
Wei, Yumeng
Zhao, Ling
author_sort Zhao, Wenmei
collection PubMed
description CONTEXT: Curcumin (Cur) has a short duration of action which limits its therapeutic efficacy. Carbonic acid 17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 4-[7-(4-hydroxy-3-methoxy-phenyl)-3,5-dioxo-hepta-1,6-dienyl]-2-methoxy-phenyl ester (CUD), as a small molecule derivative of Cur with superior stability, has been developed in our laboratory. OBJECTIVE: CUD-loaded solid lipid nanoparticles (CUD-SLN) were prepared to prolong the duration of the drug action of Cur. MATERIALS AND METHODS: CUD-SLN were prepared with Poloxamer 188 (F68) and hydrogenated soybean phospholipids (HSPC) as carriers, and the prescription was optimized. The in vitro release of CUD and CUD-SLN was investigated. CUD-SLN (5 mg/kg) was injected into Sprague Dawley (SD) rats to investigate its pharmacokinetic behaviour. RESULTS: CUD-SLN features high entrapment efficiency (96.8 ± 0.4%), uniform particle size (113.0 ± 0.8 nm), polydispersity index (PDI) (0.177 ± 0.007) and an appropriate drug loading capacity (6.2 ± 0.1%). Optimized CUD-SLN exhibited sustained release of CUD for about 48 h. Moreover, the results of the pharmacokinetic studies showed that, compared to Cur, CUD-SLN had a considerably prolonged half-life of 14.7 h, slowed its metabolism in vivo by 35.6-fold, and had an improved area under the curve (AUC(0–)(t)) of 37.0-fold. CONCLUSIONS: CUD-SLN is a promising preparation for the development of a small molecule derivative of Cur.
format Online
Article
Text
id pubmed-9704087
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-97040872022-11-29 Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo Zhao, Wenmei Zeng, Mingtang Li, Ke Pi, Chao Liu, Zerong Zhan, Chenglin Yuan, Jiyuan Su, Zhilian Wei, Yuxun Wen, Jie Pi, Fengjuan Song, Xinjie Lee, Robert J. Wei, Yumeng Zhao, Ling Pharm Biol Research Article CONTEXT: Curcumin (Cur) has a short duration of action which limits its therapeutic efficacy. Carbonic acid 17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 4-[7-(4-hydroxy-3-methoxy-phenyl)-3,5-dioxo-hepta-1,6-dienyl]-2-methoxy-phenyl ester (CUD), as a small molecule derivative of Cur with superior stability, has been developed in our laboratory. OBJECTIVE: CUD-loaded solid lipid nanoparticles (CUD-SLN) were prepared to prolong the duration of the drug action of Cur. MATERIALS AND METHODS: CUD-SLN were prepared with Poloxamer 188 (F68) and hydrogenated soybean phospholipids (HSPC) as carriers, and the prescription was optimized. The in vitro release of CUD and CUD-SLN was investigated. CUD-SLN (5 mg/kg) was injected into Sprague Dawley (SD) rats to investigate its pharmacokinetic behaviour. RESULTS: CUD-SLN features high entrapment efficiency (96.8 ± 0.4%), uniform particle size (113.0 ± 0.8 nm), polydispersity index (PDI) (0.177 ± 0.007) and an appropriate drug loading capacity (6.2 ± 0.1%). Optimized CUD-SLN exhibited sustained release of CUD for about 48 h. Moreover, the results of the pharmacokinetic studies showed that, compared to Cur, CUD-SLN had a considerably prolonged half-life of 14.7 h, slowed its metabolism in vivo by 35.6-fold, and had an improved area under the curve (AUC(0–)(t)) of 37.0-fold. CONCLUSIONS: CUD-SLN is a promising preparation for the development of a small molecule derivative of Cur. Taylor & Francis 2022-11-23 /pmc/articles/PMC9704087/ /pubmed/36606719 http://dx.doi.org/10.1080/13880209.2022.2136205 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhao, Wenmei
Zeng, Mingtang
Li, Ke
Pi, Chao
Liu, Zerong
Zhan, Chenglin
Yuan, Jiyuan
Su, Zhilian
Wei, Yuxun
Wen, Jie
Pi, Fengjuan
Song, Xinjie
Lee, Robert J.
Wei, Yumeng
Zhao, Ling
Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
title Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
title_full Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
title_fullStr Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
title_full_unstemmed Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
title_short Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
title_sort solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704087/
https://www.ncbi.nlm.nih.gov/pubmed/36606719
http://dx.doi.org/10.1080/13880209.2022.2136205
work_keys_str_mv AT zhaowenmei solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT zengmingtang solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT like solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT pichao solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT liuzerong solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT zhanchenglin solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT yuanjiyuan solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT suzhilian solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT weiyuxun solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT wenjie solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT pifengjuan solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT songxinjie solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT leerobertj solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT weiyumeng solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo
AT zhaoling solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo